click below
click below
Normal Size Small Size show me how
Platelet Disease
Hematology
Question | Answer |
---|---|
Examples of platelet disease | Acute Thrombocytopenia; HIT; ITP; TTP; HUS |
Causes of thrombocytopenia (decrease in plt numbers) | Decreased prodn (BM prob); inc destn (meds, immune mediated, DIC); Sequestration (Splenomegaly) |
ITP diagnosis is: | one of exclusion (ie, notable for what is not present) |
ITP findings | Neg FH/SH/PMH. Labs = acute thrombocytopenia; all else normal. Bruising, petechiae, gingival bleeding, hemorrhagic bullae in kids |
ITP tx | Immunosuppression (prednisone 1mg/kg/day; rituximab; cyclophosphamide ). Immune modulation (IVIg, splenectomy). Stimulate platelet production (eltrombopag, romiplostin) |
2 types of HIT | 1: transient decrease. 2: immune mediated (significant) |
HIT mechanism | Heparin combines w/PF4; this plus Abs -> platelet activation -> limb or life threatening thrombosis |
HIT PMHx | On heparin 4-10 days; Inflammation/necrosis?; limb asymmetry? ; Cool/pulseless extremities? |
HIT tx | Stop all heparin products (inc hep lines & flushes & LMWHs); prompt tx w/alt. anti-coagulation: Direct Thrombin Inhibitor (Argatroban, Lepirudin, Bivalirudin); Fondaparinux (synthetic anti-coagulant); warfarin after plt normal; w/alt anticoag; 6-12 wks |
Increase in ultra-high molecular weight multimers of von Willebrand factor (2/2 deficiency vWF proteolytic enzyme) = | TTP |
Effects of TTP | Intra-vascular platelet aggregation; systemic manifestations (CNS, Renal, Cardiac, Hematologic) |
H&P for TTP | mental status changes; Sx/Sx related to end-organ damage and those of acute & idiopathic thrombocytopenia |
TTP tx | Emergent large-volume plasma plasmapheresis; RBCs and fresh plasma returned to patient. Possible prednisone & antiplatelet tx |
Platelet release involves: | Release of PF3 (Platelet factor 3); intracellular Ca (enhances further activation); thromboxane A2 |
Adult ITP is usually: | chronic (as opposed to children, no viral infxn). |
Most common drug causing ITP | Heparin |
TTP clinical findings | Pentad: MAHA; thrombocytopenia; CNS abnormalities; fever; renal dysfunction |
HUS: mental status changes? | No |
HUS findings | Thrombocytopenia |
Dx similar to TTP but without neuro symptoms | HUS |
AutoAb to ADAMTS13 seen in: | TTP |
HUS prognosis | Self-limiting in kids. 40% mortality in adults; CKD in 80% |
Platelet aggregation abnormal with ristocetin, which corrects with the addition of normal platelets, in: | Bernard-Soulier Syndrome |
HIT involves: | IgG antibody to Platelet Factor 4 |
Confirm HIT with: | Serotonin Release Assay |
Most common drug induced form of thrombocytopenia | HIT |
HIT type I | Non-immune mediated: 100K platelets, no thrombosis (dc heparin) |
HIT type II | Immune mediated: 30K platelets, thrombosis risk (require dc heparin, Rx direct thrombin inhibitors & warfarin) |
HUS tx | D+ HUS: supportive; NO PLTS, NO ABX. Plasmapheresis & FFP |
IgG antibody to PF4: seen in: | HIT (both art & venous thrombosis) |
Microangiopathic hemolytic anemia & thrombocytopenia without an identifiable cause = | TTP (also often see neuro sxs) |
anemia with schistocytes, thrombocytopenia & renal dysfunction in the absence of other causes of coagulopathy = | HUS |
DIC vs HUS: dx | DIC low fibrinogen; HUS normal fibrinogen |
Anagrelide may be used for: | P vera; thrombocytosis |
Bleeding disorder clinical findings: platelet vs coagulopathy | plt: mucosa & skin; petechiae in low plt (NOT plt dysfn); coag: skin & mx; spont hemarthrosis in severe hemophilia |
most common cause of abnormal bleeding: | thrombocytopenia |
HUS vs TTP | HUS: no neuro sxs, more renal > TTP |
Causes of decreased platelet function: membrane defects | Glanzmann Thrombasthenia; Bernard-Soulier |
Causes of decreased platelet function: Pathway Defects | Arachidonic Pathway Defect |
Causes of decreased platelet function: medications | Aspirin/Clopidogrel use |
Causes of decreased platelet function: acquired disease | MDS |
Diseases causing ITP | SLE, CLL, virus (HIV/Hep C) |
von W defect is in: | platelet adhesion only |
HIT occurs when? | 4-10 days post heparin infusion |
Adult ITP epidemiology | Peak = 20-50 y.o. (2-4 yo in kids). F:M = 2:1 |
ITP etiology | Acquired autoimmune. Isolated thrombocytopenia. Autoantibody binds to platelet membrane antigen -> bound to splenic macrophages & destroyed in spleen -> low platelets 2/2 splenic sequestration & accelerated platelet destruction |